サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1643969

ラテラルフロー免疫測定法（LFIA）に基づく迅速検査の世界市場：2033年までの機会と戦略

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Opportunities And Strategies To 2033

出版日
ページ情報
英文 293 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.82円
ラテラルフロー免疫測定法（LFIA）に基づく迅速検査の世界市場：2033年までの機会と戦略
出版日: 2025年01月27日
発行: The Business Research Company
ページ情報: 英文 293 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のラテラルフロー免疫測定法（LFIA）に基づく迅速検査の市場は、2018年に68億8,441万米ドルと評価され、2023年まで5.00％以上のCAGR（複合年間成長率）で成長しました。

感染症の高い有病率

感染症の大きな流行が、実績期間にLFIAに基づく迅速検査市場の成長を牽引しました。インフルエンザ、COVID-19、さまざまなウイルスや細菌感染などの疾病の世界での発生が増加し、迅速で正確な結果を提供できる迅速診断ソリューションへの需要が高まりました。LFIA検査は、その使いやすさと専門的な機器の最小限の必要性で知られ、タイムリーな疾患の検出と管理を可能にするヘルスケア環境にとって極めて重要なものとなりました。例えば、スイスに本部を置く国際的な非政府組織である世界経済フォーラムによると、2023年には、インフルエンザやRSウイルス（RSV）などの感染症がパンデミック以降増加しています。米国では、2023年2月の時点で、インフルエンザによる推定罹患者数は2,400万人、入院者数は26万人、死亡者数は1万6,000人となっています。さらに、世界最大の生物医学図書館である国立医学図書館によると、2022年、オランダでは、0～5歳児の侵襲性化膿レンサ球菌（iGAS）感染報告数が、COVID-19パンデミック以前に比べて7倍に増加しました。したがって、感染症の高い流行がLFIAに基づく迅速検査市場の成長を牽引しました。

目次

第1章 エグゼクティブサマリー

  • ラテラルフロー免疫測定法（LFIA）に基づく迅速検査-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • ラテラルフロー免疫測定法（LFIA）に基づく迅速検査市場定義とセグメンテーション
  • 市場セグメンテーション：技術別
    • 競合アッセイ
    • サンドイッチアッセイ
    • マルチプレックス検出アッセイ
  • 市場セグメンテーション：用途別
    • 感染症
    • 妊娠と不妊
    • 毒物学
    • 心臓マーカーとコレステロール検査
    • その他の用途
  • 市場セグメンテーション：エンドユーザー別
    • 病院・クリニック
    • 診断検査室
    • ホームケア
    • その他のエンドユーザー

第7章 主要な市場動向

  • 危機的な健康緊急事態の迅速な管理のためのポータブルポイントオブケア診断への注力
  • より長い保存期間を持つLFIA迅速検査を導入するための進展

第8章 ラテラルフロー免疫測定法（LFIA）に基づく迅速検査市場- マクロ経済シナリオ

  • COVID-19の影響：ラテラルフロー免疫測定法（LFIA）に基づく迅速検査市場
  • ウクライナ戦争の影響：ラテラルフロー免疫測定法（LFIA）に基づく迅速検査市場
  • 高インフレの影響：ラテラルフロー免疫測定法（LFIA）に基づく迅速検査市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績、2018～2023年
    • 市場促進要因、2018～2023年
    • 市場抑制要因、2018～2023年
  • 市場成長予測、2023～2028年、2033年
    • 市場促進要因、2023～2028年
    • 市場抑制要因、2023～2028年

第10章 世界のラテラルフロー免疫測定法（LFIA）に基づく迅速検査市場：セグメンテーション

  • 世界のラテラルフロー免疫測定法（LFIA）に基づく迅速検査市場：技術別、実績と予測、2018～2023年、2028年、2033年
  • 世界のラテラルフロー免疫測定法（LFIA）に基づく迅速検査市場：用途別、実績と予測、2018～2023年、2028年、2033年
  • 世界のラテラルフロー免疫測定法（LFIA）に基づく迅速検査市場：エンドユーザー別、実績と予測、2018～2023年、2028年、2033年

第11章 ラテラルフロー免疫測定法（LFIA）に基づく迅速検査市場：地域・国別分析

  • 世界のラテラルフロー免疫測定法（LFIA）に基づく迅速検査市場：地域別、実績と予測、2018～2023年、2028年、2033年
  • 世界のラテラルフロー免疫測定法（LFIA）に基づく迅速検査市場：国別、実績と予測、2018～2023年、2028年、2033年

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Abbott Laboratories
  • F. Hoffman-La Roche Ltd
  • Thermo Fisher Scientific Inc
  • Siemens AG
  • Danaher Corporation

第20章 その他の大手企業と革新的企業

  • Hologic, Inc
  • bioMerieux SA
  • Becton, Dickinson and Company
  • Merck KGaA
  • Bio-Rad Laboratories, Inc
  • QIAGEN N.V.
  • EKF Diagnostics
  • QuidelOrtho Corporation
  • Launch Diagnostics
  • JOYSBIO（Tianjin）Biotechnology Co., Ltd
  • INDICAL Bioscience
  • Ubio Biotechnology Systems
  • Jiangsu Medomics Medical Technologies
  • Atomo Diagnostics Limited
  • PerkinElmer Inc

第21章 競合ベンチマーキング

第22章 競合ダッシュボード

第23章 主要な合併と買収

  • Danaher Corporation Acquired Abcam plc
  • Becton, Dickinson and Company Acquired Scanwell Health
  • DiaSorin Acquired Luminex Corporation For$1.8 Billion
  • PerkinElmer Inc. Acquired Immunodiagnostic Systems Holdings PLC
  • Hologic Inc. Acquired Mobidiag
  • Thermo Fisher Scientific Acquired Mesa Biotech Inc.

第24章 機会と戦略

  • 世界のラテラルフロー免疫測定法（LFIA）に基づく迅速検査市場2028年：新たな機会を提供する国
  • 世界のラテラルフロー免疫測定法（LFIA）に基づく迅速検査市場2028年：新たな機会を提供するセグメント
  • 世界のラテラルフロー免疫測定法（LFIA）に基づく迅速検査市場2028年：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第25章 ラテラルフロー免疫測定法（LFIA）に基づく迅速検査市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第26章 付録

目次
Product Code: o&s1432

Lateral flow immunoassay (LFIA) based rapid tests are diagnostic tools used to detect the presence or absence of specific substances in a sample, often delivering results within a short time. These tests are a critical component in medical diagnostics, leveraging antibodies to identify biomarkers related to various conditions.

The LFIA based rapid test market consists of sales of LFIA based rapid test equipment used to run LFIA based rapid test and related services. These are testing devices used to assess the existence of a target, such as pathogens or biomarkers, in samples of urine, blood or saliva obtained from the human body.

The global lateral flow immunoassay (LFIA) based rapid test market was valued at $6,884.41 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 5.00%.

High Prevalence Of Infectious Diseases

The high prevalence of infectious diseases drove the growth of the LFIA based rapid test market during the historic period. Increased global outbreaks of diseases such as influenza, COVID-19 and various viral and bacterial infections heightened the demand for rapid diagnostic solutions that could provide quick and accurate results. LFIA tests, known for their ease of use and minimal requirement for specialized equipment, became crucial for healthcare settings, enabling timely disease detection and management. For instance, in 2023, according to the World Economic Forum, a Switzerland-based international non-governmental organization, infections such as influenza and respiratory syncytial virus (RSV) have increased since the pandemic. In the USA, an estimated 24 million illnesses, 260,000 hospitalizations and 16,000 deaths from the influenza have occurred as of February 2023. Additionally, in 2022, according to the National Library of Medicine, the world's largest biomedical library, the Netherlands saw a sevenfold rise in the number of reportable invasive Streptococcus pyogenes (iGAS) infections among children aged 0-5, compared to the years before the COVID-19 pandemic. Therefore, the high prevalence of infectious diseases drove the growth of the LFIA based rapid test market.

Focus On Portable Point-Of-Care Diagnostics For Rapid Management Of Critical Health Emergencies

Major companies operating in the LFIA based rapid test market are focusing on portable, point-of-care diagnostics that prioritize speed, ease of use and specificity to manage critical health emergencies effectively. By advancing tests that deliver rapid results, these companies aim to support timely decision-making in emergency settings, such as stroke and cardiac events, where immediate diagnosis can significantly impact patient outcomes. For example, in February 2024, Upfront Diagnostics, a UK-based healthcare company, planned to launch LVOne test, a rapid diagnostic tool designed to identify large vessel occlusion (LVO) strokes within 15 minutes using a fingerprick blood sample. It employs two portable lateral flow assays to detect specific biomarkers, the fibrin degradation D-dimer and glial fibrillary acidic protein (GFAP) from capillary blood. These biomarkers help paramedics quickly triage stroke patients, enabling faster transport to specialized stroke centers for urgent treatment.

The global lateral flow immunoassay (LFIA) based rapid test market is fairly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up to 22.95% of the total market in 2023.

Lateral Flow Immunoassay (LFIA) Based Rapid Test Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global lateral flow immunoassay (LFIA) based rapid test market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for lateral flow immunoassay (LFIA) based rapid test? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The lateral flow immunoassay (LFIA) based rapid test market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider lateral flow immunoassay (LFIA) based rapid test market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technique, by application and by end-users.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the LFIA based rapid test.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by technique, by application and by end-users in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies-Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for LFIA based rapid test providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Technique: Competitive Assay; Sandwich Assay; Multiplex Detection Assay
  • 2) By Application: Infectious Disease; Pregnancy And Fertility; Toxicology; Cardiac Marker And Cholesterol Testing; Other Applications
  • 3) By End-Users: Hospitals And Clinics; Diagnostic Laboratories; Home Care; Other End-Users
  • Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Siemens AG; Danaher Corporation
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; lateral flow immunoassay (LFIA) based rapid test indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Lateral Flow Immunoassay (LFIA) Based Rapid Test - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Definition And Segmentations
  • 6.4 Market Segmentation By Technique
    • 6.4.1 Competitive Assay
    • 6.4.2 Sandwich Assay
    • 6.4.3 Multiplex Detection Assay
  • 6.5 Market Segmentation By Application
    • 6.5.1 Infectious Disease
    • 6.5.2 Pregnancy And Fertility
    • 6.5.3 Toxicology
    • 6.5.4 Cardiac Marker And Cholesterol Testing
    • 6.5.5 Other Applications
  • 6.6 Market Segmentation By End-Users
    • 6.6.1 Hospitals And Clinics
    • 6.6.2 Diagnostic Laboratories
    • 6.6.3 Home Care
    • 6.6.4 Other End-Users

7 Major Market Trends

  • 7.1 Focus On Portable Point-Of-Care Diagnostics For Rapid Management Of Critical Health Emergencies
  • 7.2 Advancements To Introduce LFIA Rapid Tests That Have Longer Shelf Life

8 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market - Macro-Economic Scenario

  • 8.1 COVID-19 Impact On The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market
  • 8.2 Impact Of The War In Ukraine On The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market
  • 8.3 Impact Of High Inflation On The Lateral Flow Immunoassay (LFIA) Based Rapid Test Market

9 Global Market Size And Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Segmentation

  • 10.1 Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Regional and Country Analysis

  • 11.1 Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate Tax Structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.6 Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market: Country Analysis
  • 12.7 China Market
  • 12.8 Summary
  • 12.9 Market Overview
    • 12.9.1 Country Information
    • 12.9.2 Market Information
    • 12.9.3 Background Information
    • 12.9.4 Government Initiatives
    • 12.9.5 Regulations
    • 12.9.6 Regulatory Bodies
    • 12.9.7 Major Associations
    • 12.9.8 Taxes Levied
    • 12.9.9 Corporate Tax Structure
    • 12.9.10 Investments
    • 12.9.11 Major Companies
  • 12.10 China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.12 China Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 India Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Market
  • 12.18 Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.20 Japan Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Market
  • 12.22 Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.24 Australia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Market
  • 12.26 Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.28 Indonesia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Market
  • 12.30 South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.31 South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.32 South Korea Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Investments
    • 13.2.11 Major Companies
  • 13.3 Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.6 Western Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market: Country Analysis
  • 13.7 UK Market
  • 13.8 UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 UK Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.11 Germany Market
  • 13.12 Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 Germany Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.15 France Market
  • 13.16 France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 France Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.19 Italy Market
  • 13.20 Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Italy Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.23 Spain Market
  • 13.24 Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.26 Spain Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Major Companies
  • 14.3 Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.6 Eastern Europe Lateral Flow Immunoassay (LFIA) Based Rapid Test Market: Country Analysis
  • 14.7 Russia Market
  • 14.8 Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.10 Russia Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.6 North America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market: Country Analysis
  • 15.7 USA Market
  • 15.8 Summary
  • 15.9 Market Overview
    • 15.9.1 Country Information
    • 15.9.2 Market Information
    • 15.9.3 Background Information
    • 15.9.4 Government Initiatives
    • 15.9.5 Regulations
    • 15.9.6 Regulatory Bodies
    • 15.9.7 Major Associations
    • 15.9.8 Taxes Levied
    • 15.9.9 Corporate Tax Structure
    • 15.9.10 Investments
    • 15.9.11 Major Companies
  • 15.11 USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.12 USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 USA Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Market
  • 15.15 Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.16 Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.17 Canada Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Major Companies
  • 16.3 South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.6 South America Lateral Flow Immunoassay (LFIA) Based Rapid Test Market: Country Analysis
  • 16.7 Brazil Market
  • 16.8 Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.10 Brazil Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.5 Middle East Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
  • 18.2 Market Overview
    • 18.2.1 Region Information
    • 18.2.2 Market Information
    • 18.2.3 Background Information
    • 18.2.4 Government Initiatives
    • 18.2.5 Regulations
    • 18.2.6 Regulatory Bodies
    • 18.2.7 Major Associations
    • 18.2.8 Taxes Levied
    • 18.2.9 Corporate Tax Structure
    • 18.2.10 Major Companies
  • 18.3 Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Technique, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.5 Africa Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Abbott Laboratories
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Financial Overview
  • 19.3 F. Hoffman-La Roche Ltd
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Thermo Fisher Scientific Inc
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Financial Overview
  • 19.5 Siemens AG
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Danaher Corporation
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Financial Overview

20 Other Major And Innovative Companies

  • 20.1 Hologic, Inc
    • 20.1.1 Company Overview
    • 20.1.2 Products and Services
  • 20.2 bioMerieux SA
    • 20.2.1 Company Overview
    • 20.2.2 Products and Services
  • 20.3 Becton, Dickinson and Company
    • 20.3.1 Company Overview
    • 20.3.2 Products and Services
  • 20.4 Merck KGaA
    • 20.4.1 Company Overview
    • 20.4.2 Products and Services
  • 20.5 Bio-Rad Laboratories, Inc
    • 20.5.1 Company Overview
    • 20.5.2 Products and Services
  • 20.6 QIAGEN N.V.
    • 20.6.1 Company Overview
    • 20.6.2 Products and Services
  • 20.7 EKF Diagnostics
    • 20.7.1 Company Overview
    • 20.7.2 Products and Services
  • 20.8 QuidelOrtho Corporation
    • 20.8.1 Company Overview
    • 20.8.2 Products and Services
  • 20.9 Launch Diagnostics
    • 20.9.1 Company Overview
    • 20.9.2 Products and Services
  • 20.10 JOYSBIO (Tianjin) Biotechnology Co., Ltd
    • 20.10.1 Company Overview
    • 20.10.2 Products and Services
  • 20.11 INDICAL Bioscience
    • 20.11.1 Company Overview
    • 20.11.2 Products and Services
  • 20.12 Ubio Biotechnology Systems
    • 20.12.1 Company Overview
    • 20.12.2 Products and Services
  • 20.13 Jiangsu Medomics Medical Technologies
    • 20.13.1 Company Overview
    • 20.13.2 Products and Services
  • 20.14 Atomo Diagnostics Limited
    • 20.14.1 Company Overview
    • 20.14.2 Products and Services
  • 20.15 PerkinElmer Inc
    • 20.15.1 Company Overview
    • 20.15.2 Products and Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

  • 23.1 Danaher Corporation Acquired Abcam plc
  • 23.2 Becton, Dickinson and Company Acquired Scanwell Health
  • 23.3 DiaSorin Acquired Luminex Corporation For $1.8 Billion
  • 23.4 PerkinElmer Inc. Acquired Immunodiagnostic Systems Holdings PLC
  • 23.5 Hologic Inc. Acquired Mobidiag
  • 23.6 Thermo Fisher Scientific Acquired Mesa Biotech Inc.

24 Opportunities And Strategies

  • 24.1 Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2028 - Countries Offering Most New Opportunities
  • 24.2 Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2028 - Segments Offering Most New Opportunities
  • 24.3 Global Lateral Flow Immunoassay (LFIA) Based Rapid Test Market In 2028 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer